Biopharmas invested $51.2bn in 2014
This article was originally published in Scrip
Executive Summary
The Pharmaceutical Research and Manufacturers of America (PhRMA) on 20 April said its members invested about $51.2bn in the research and development (R&D) of new innovative treatments and cures in 2014.